Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...

Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...

It is a truth universally acknowledged that our genetic makeup has an influence over our lives. There are plenty of areas of ...

The human genome is like a big ball of yarn, made up of 3 billion molecular units arranged in sequence and then wrapped up ...

"We built our platform to systematically address transcription factors, a target class long considered out of reach for small-molecule therapeutics," said Alex Federation, PhD, CEO and Co-Founder of ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

In further support of that finding, the researchers determined—with the help of AI—that PHGDH plays a previously undiscovered ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

Kendall Square has become a hub of biotech innovation and a popular location for up and coming life sciences firms. Now, a ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...